KMT2A and cancer: The authors of this report showed that Fendrr binds to cancer related complexes like both PRC2 and TrxG/MLL, suggesting that it acts as modulator of chromatin signatures that define gene activity and to contribute to cell identity and differentiation, a feature lost during the tumor development.